Brighton Jones’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Brighton Jones's ALNY Position: Q3 2026 in Review
Brighton Jones increased its Alnylam Pharmaceuticals (ALNY) stake by 42% in Q3 2026, buying an estimated $527K and bringing the position to 6,967 shares worth $1.72M. The position accounts for 0.03% of the portfolio, ranked #349.
Brighton Jones first reported a position in ALNY in Q3 2016 and has held it in 16 quarters since. The position peaked at $2.25M in Q3 2025. 591 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Brighton Jones held 6,967 shares of Alnylam Pharmaceuticals worth $1.72M as of Q3 2026.
- Brighton Jones bought 2,069 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $527K.
- Alnylam Pharmaceuticals made up 0.03% of Brighton Jones's portfolio in Q3 2026, its #349 holding.
- Brighton Jones first reported a position in Alnylam Pharmaceuticals in Q3 2016 and has held it in 16 quarters since.
- Brighton Jones's Alnylam Pharmaceuticals position peaked at $2.25M in Q3 2025.
- 591 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.